Skip to main content
. 2014 Feb 4;18(5):863–874. doi: 10.1111/jcmm.12232

Fig. 5.

Fig. 5

Cumulative survival curve of patients with endometrioid adenocarcinoma and expression levels of Olfactomedin 4 (A), oestrogen receptor-α (B) and progesterone receptor (C).